PT  - JOURNAL ARTICLE
AU  - Md. Sayeed Al-Zaman
TI  - Bibliometric analysis of COVID-19 literature
AID  - 10.1101/2020.07.15.20154989
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.15.20154989
4099  - http://medrxiv.org/content/early/2020/07/19/2020.07.15.20154989.short
4100  - http://medrxiv.org/content/early/2020/07/19/2020.07.15.20154989.full
AB  - This study analyzes N=16384 COVID-19-related literature published between December 2019 to June 2020. The data were extracted from the Web of Science database using four keywords: “COVID-19”, “Coronavirus”, “2019-nCoV”, and “SARS-CoV-2”. The analysis found that almost all but a tiny number of the papers are published in 2020 (95.16%). Of the 15 types of publications, article (40.015%) is on the top of the list. All publications are in 19 different languages where English (95.313%) is the dominant one. A total of 159 countries produce COVID-19-related researches, and the USA (25.433%) is in the leading position. According to the findings, Wang Y (n=94) is the top author, and the British Medical Journal (BMJ) (n=488) is the top source. Also, the University of London (n=488) is the leading organization with the highest number of papers, and medicine-related papers (n=2259) are the highest in numbers. Apart from these novel findings, this study is perhaps the largest COVID-19-related bibliometric analysis to date.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A